Matches in Nanopublications for { ?s ?p "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP488487.RA6puliCsYiPzVayisRZbi_y-OkupTVy-GNVt08acsa2E130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488487.RA6puliCsYiPzVayisRZbi_y-OkupTVy-GNVt08acsa2E130_provenance.
- assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP780146.RAc_ZixxBX9rFMch6AqevBdo1ywTJ5U3u0RI3xxfNFpDc130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780146.RAc_ZixxBX9rFMch6AqevBdo1ywTJ5U3u0RI3xxfNFpDc130_provenance.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.
- NP1114974.RAZ4D95WB10EohR-Wm4cWD0-KzLOxpMJGuWjP6uzzANcM130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1114974.RAZ4D95WB10EohR-Wm4cWD0-KzLOxpMJGuWjP6uzzANcM130_provenance.
- NP1114978.RAmswzAcB2ZNoReCsYZPWKjryfHSimG6nStxnCNTUX_5U130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1114978.RAmswzAcB2ZNoReCsYZPWKjryfHSimG6nStxnCNTUX_5U130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP1114977.RA_VmrfnLAzs8JZZ5bW8zhkK10WQzPVCiar_xe5r8a2Jc130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1114977.RA_VmrfnLAzs8JZZ5bW8zhkK10WQzPVCiar_xe5r8a2Jc130_provenance.